The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a ...

Spirulina is a nutrient-dense cyanobacterium rich in proteins, phycobiliproteins, carotenoids, and polyphenols that deliver ...

Lentils are a nutrient-dense food that boasts many health benefits. For instance, lentils are a good source of protein, ...

Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for patients with overweight or obesity in an early study, researchers reported.

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety ...

Promising efficacy data with median PFS of 7.2 months (95%CI 5.6-9.2), median OS of 13.7 months (95%CI 11.1-18.3), and 1-year survival ...

The Pelvic Inflammatory Disease Evaluation and Clinical Health Randomized Trial (PEACH) provides the best guidance regarding the antibiotic therapy of women with mild-to-moderate PID.

These biomarkers developed through analysis of DNA methylation appear to be the first ones able to predict response to ...

A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflam ...